Tumor necrosis factor-α induces neuronal death by silencing survival signals generated by the type I insulin-like growth factor receptor

Annals of the New York Academy of Sciences

Volumn 917, Issue , 2000, Pages 210-220

  Venters, H D ^a   Dantzer, R ^b   Kelley, K W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN ISCHEMIA; CELL SURVIVAL; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

EID: 0033670002     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05385.x     Document Type: Conference Paper

References (54)

1. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60
2. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
3. A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide
4. The role of neuronal growth factors in neurodegenerative disorders of the human brain
5. The changing landscape of ischaemic brain injury mechanisms
6. Detection of higher-order 50- and 10-kbp DNA fragments before apoptotic internucleosomal cleavage after transient cerebral ischemia
7. Insights into the neurodegenerative process of Alzheimer's disease: A role for mononuclear phagocyte-associated inflammation and neurotoxicity
8. Neuroprotective role of IL-4 against activated microglia
9. Platelet-activating factor receptor activation: An initiator step in HIV-1 neuropathogenesis
10. Early neuronal expression of tumor necrosis factor-α after experimental brain injury contributes to neurological impairment
11. Tumor necrosis factor-α. A mediator of focal ischemic brain injury
12. Neuroprotective effects of TNF binding protein in focal cerebral ischemia
13. HIV-1 Tat induces neuronal death via tumor necrosis factor-α and activation of non-N-methyl-D-aspartate receptors by a NFκB-independent mechanism
14. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α: Potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia
15. Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin
16. Local production of TGF beta 1 inhibits cerebral edema, enhances TNF-α induced apoptosis and improves survival in a murine glioma model
17. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
18. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
19. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase
20. Signal transduction of stress via ceramide
21. Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines
22. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
23. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
24. Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administration
25. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors
26. Regulation of neuronal survival by the serine-threonine protein kinase Akt
27. Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: An electron microscopic study
28. 125I]insulin receptor binding sites in developing and adult rat brain
29. Rediscovering an old friend, IGF-I: Potential use in the treatment of neurodegenerative diseases
30. Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury
31. Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia
32. Insulin-like growth factor-I attenuates apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats
33. The movement of IGF-I into the brain parenchyma after hypoxic-ischaemic injury
34. Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke
35. Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts
36. Insulin-like growth factor I modulates c-Fos induction and astrocytosis in response to neurotoxic insult
37. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice
38. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats
39. The regulation of IGF-I receptor gene expression
40. The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action
41. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes
42. Signalling through the lipid products of phosphoinositide-3-OH kinase
43. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappa β
44. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-α-induced injury
45. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis
46. Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: Role of Fas
47. Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures
48. Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-κB
49. Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase
50. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation
51. TNF inhibits insulin induced STAT5 activation in differentiated mouse muscle cells pmi28
52. Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis
53. Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-α in the rat
54. A new concept in neurodegeneration: TNFα is a silencer of survival signals (SOSS)